Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

We compared the effects of GK-2 (dimeric dipeptide mimetic of nerve growth factor) and Mexidol (standard preparation for the therapy of stroke) on rat model of transient occlusion of the middle cerebral artery. GK-2 and Mexidol were administered intraperitoneally in the most active doses (1 and 100 mg/kg, respectively) 6 h after surgery and then once a day for 6 days. The preparations reduced the volume of cerebral infarction (by 60 and 30%, respectively). At the same time, GK-2 had a pronounced and statistically more reliable effect in a dose that is lower by two orders of magnitude. In addition, GK-2 significantly reduced the neurological deficit in the limb placement test, while Mexidol was ineffective in this test.

作者简介

P. Povarnina

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

编辑信件的主要联系方式.
Email: povarnina@gmail.com
俄罗斯联邦, Moscow

A. Volkova

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
俄罗斯联邦, Moscow

T. Gudasheva

Laboratory of Peptide Bioregulation, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
俄罗斯联邦, Moscow

S. Seredenin

Department of Pharmacogenetics, V. V. Zakusov Research Institute of Pharmacology

Email: povarnina@gmail.com
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2017
##common.cookie##